The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
A randomized, double‐blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia
Abstract
Objective. To study the effect of fluoxetine (FL) and amitriptyline (AM), alone and in combination, in patients with fibromyalgia (FM). Methods. Nineteen patients with FM completed a randomized, double‐blind crossover study, which consisted of 4 6‐week trials of FL (20 mg), AM (25 mg), a combination of FL and AM, or placebo. Patients were evaluated on the first and last day of each trial period. Outcome measures included a tender point score, the Fibromyalgia Impact Questionnaire (FIQ), the Beck Depression Inventory (BDI) scale, and visual analog scales (VAS) for global well‐being (1 completed by the physican and 1 by the patient), pain, sleep trouble, fatigue, and feeling refreshed upon awakening. Results. Both FL and AM were associated with significantly improved scores on the FIQ and on the VAS for pain, global well‐being, and sleep disturbances. When combined, the 2 treatments worked better than either medication alone. Similar, but nonsignificant, improvement occurred in the BDI scale, the physician global VAS, and the VAS for fatigue and feeling refreshed upon awakening. Trends were less clear for the tender point score. Conclusion. Both FL and AM are effective treatments for FM, and they work better in combination than either medication alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Self-citationStatistical Analysis with Missing Data
Bo., N., Little, R. J. A., & Rubin, D. B. (1988) · Population (French Edition) · doi:10.2307/1533221 · Cited by 2,095
(1991) · PubMed · Cited by 1,837
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
Elevated cerebrospinal fluid levels of substance p in patients with the fibromyalgia syndrome
Russell, I. J., Orr, M. D., Littman, B., Vipraio, G. A., Alboukrek, D., Michalek, J. E., Lopez, Y., & Mackillip, F. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371106 · Cited by 679
Russell, I. J., Vaeroy, H., Javors, M., & Nyberg, F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350509 · Cited by 547
Hypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia
Crofford, L. J., Pillemer, S. R., Kalogeras, K. T., Cash, J. M., Michelson, D., Kling, M. A., Sternberg, E. M., Gold, P. W., Chrousos, G. P., & Wilder, R. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371105 · Cited by 508
Goldenberg, D. L., Felson, D. T., & Dinerman, H. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291110 · Cited by 439
Self-citationThe impact of a meditation-based stress reduction program on fibromyalgia.
Kaplan, K. H., Goldenberg, D. L., & Galvin-Nadeau, M. (1993) · General Hospital Psychiatry · doi:10.1016/0163-8343(93)90020-o · Cited by 345
Self-citationComparison of Amitriptyline, Cyclobenzaprine, and Placebo in the Treatment of Fibromyalgia
Carette, S., Bell, M. J., Reynolds, W. J., Haraoui, B., Mccain, G. A., Bykerk, V. P., Edworthy, S. M., Baron, M., Koehler, B. E., Fam, A. G., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370106 · Cited by 340
Evaluation of amitriptyline in primary fibrositis. A double‐blind, placebo‐controlled study
Carette, S., McCain, G. A., Bell, D. A., & Fam, A. G. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290510 · Cited by 303
Population study of tender point counts and pain as evidence of fibromyalgia
Croft, P., Schollum, J., & Silman, A. (1994) · BMJ · doi:10.1136/bmj.309.6956.696 · Cited by 277
Russell, I. J., Michalek, J. E., Vipraio, G. A., Fletcher, E. M., Javors, M. A., & Bowden, C. L. (1992) · PubMed · Cited by 258
A Double-blind Placebo Controlled Trial of Fluoxetine in Fibromyalgia
Wolfe, F., Cathey, M. A., & Hawley, D. J. (1994) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749409103725 · Cited by 252
Bennett, R. M., Clark, S. R., Campbell, S. M., & Burckhardt, C. S. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351002 · Cited by 236
A comparison of cyclobenzaprine and placebo in the management of fibrositis
Bennett, R. M., Gatter, R. A., Campbell, S. M., Andrews, R. P., Clark, S. R., & Scarola, J. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780311210 · Cited by 191
Cross-Over Trials in Clinical Research
Ziegel, E. R., & Senn, S. (1994) · Technometrics · doi:10.2307/1270263 · Cited by 177
Carette, S., Oakson, G., Guímont, C., & Steriade, M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380906 · Cited by 148
Jaeschke, R., Adachi, J., Guyatt, G. H., Keller, J., & Wong, B. S. S. (1991) · PubMed · Cited by 125
Crossover Trials in Clinical Research
Smith, J. J. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90050-9 · Cited by 110
The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia.
Reynolds, W. J., Moldofsky, H., Saskin, P., & Lue, F. A. (1991) · PubMed · Cited by 96
van der Kraan, P., Vitters, E. L., & van den Berg, W. (1992) · PubMed · Cited by 90
A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.
Quimby, L. G., Gratwick, G. M., Whitney, C. D., & Block, S. R. (1989) · PubMed · Cited by 80
Schanberg, L. E., Kredich, D. W., Keefe, F. J., Lefebvre, J. C., & Gil, K. M. (1996) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199604)9:2<105::aid-anr1790090206>3.0.co;2-# · Cited by 80
Double-Blind Study of Dothiepin versus Placebo in the Treatment of Primary Fibromyalgia Syndrome
Caruso, I., Puttini, P. C. S., Boccassini, L., Santandrea, S., Locati, M., Volpato, R., Montrone, F., Benvenuti, C., & Beretta, A. (1987) · Journal of International Medical Research · doi:10.1177/030006058701500305 · Cited by 68
Development of preliminary criteria for response to treatment in fibromyalgia syndrome.
Simms, R. W., Felson, D. T., & Goldenberg, D. L. (1991) · PubMed · Cited by 60
Self-citationPituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome.
Griep, E. N., Boersma, J. W., & de Kloet, E. R. (1994) · PubMed · Cited by 59
URROWS, S. T., Affleck, G. G., Tennen, H. A., & Higgins, P. S. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371016 · Cited by 46
Imipramine for the treatment of fibrositis: a therapeutic trial.
Wysenbeek, A. J., Mor, F., Lurie, Y., & Weinberger, A. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.11.752 · Cited by 44
Treatment of fibrositis with fluoxetine hydrochloride (PROZAC®)
Geller, S. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90707-9 · Cited by 34
Cited by
Functional somatic syndromes: one or many?
Wessely, S., Nimnuan, C., & Sharpe, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08320-2 · Cited by 1,211
Management of fibromyalgia syndrome
Goldenberg, D. L. (2004) · JAMA · doi:10.1001/jama.292.19.2388 · Cited by 850
“cebo in a number of outcome measures in patients with FMS.(46) The combination of the 2 medications was better”
BackgroundSelf-citationKlempner, M. S., Hu, L. T., Evans, J., Schmid, C. H., Johnson, G. M., Trevino, R. P., Norton, D., Levy, L., Wall, D., McCall, J., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450202 · Cited by 758
Self-citationEULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Arnold, L. M., Lu, Y., Crofford, L. J., Wohlreich, M., Detke, M. J., Iyengar, S., & Goldstein, D. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20485 · Cited by 624
“with the tricyclic agents amitriptyline and cyclobenzaprine, and with the SSRI fluoxetine, which found no significant relationship between improvement in fibromyalgia symptoms and change in depression scores, although none of these prior studies evaluated the impact of currently diagnosed major depressive disorder (12…”
BackgroundResult
Metadata
- Authors
- Goldenberg, D., Mayskiy, M., Mossey, C., Ruthazer, R., & Schmid, C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-11
- Volume
- 39
- Issue
- 11
- Pages
- 1852-1859
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1990180765
- Cited by
- 420
- References
- 31
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.